Publications by authors named "Alvin Wells"

Claim this Profile
U
Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatment.
Ernest H Choy, Sebastian H Unizony, Alvin F Wells, Bhaskar Dasgupta, Frank Buttgereit

Ann Rheum Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy.
Kevin L Winthrop, Justin Klaff, Sara K Penn, Yanxi Liu, Conrado García, Alvin F Wells

RMD Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging in vasculitis.
Orrin M Troum, Olga L Pimienta, Alvin Wells

Curr Opin Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Disparities in Rheumatology in the United States.
Grace C Wright, Patrick M Zueger, Catherine Copley-Merriman, Shahnaz Khan, Jessica Costello, Alvin F Wells

Open Access Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND.
Ronald F van Vollenhoven, Stephen Hall, Alvin F Wells, Sebastian Meerwein, Yanna Song

RMD Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review.
Jessica R Allegretti, Jessica H Brady, Ann Wicker, Mark Latymer, Alvin Wells

Adv Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.
Alan Kivitz, Alvin F Wells, Juan I Vargas, Herbert S B Baraf, Maureen Rischmueller

Rheumatol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis.
Philip J Mease, Arthur Kavanaugh, Alexis Ogdie, Alvin F Wells, Martin Bergman

J Rheumatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists.
Alice B Gottlieb, Alvin F Wells, Joseph F Merola

Clin Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients.
Alvin F Wells, Christopher J Edwards, Alan J Kivitz, Paul Bird, Benoit Guerette

Rheumatology (Oxford)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.
Stanley Cohen, Alvin F Wells, Jeffrey R Curtis, Rajat Dhar, Theodore Mellors

Rheumatol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY.
Vibeke Strand, Namita Tundia, Alvin Wells, Maya H Buch, Sebastiao C Radominski

Rheumatology (Oxford)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study.
Alvin F Wells, Bochao Jia, Li Xie, Guillermo J Valenzuela, Edward C Keystone

Rheumatol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs.
Alvin F Wells, Janie Parrino, Erin K Mangan, Anne Paccaly, Yong Lin

Rheumatol Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial.
Alvin F Wells, Christopher J Edwards, Alan J Kivitz, Paul Bird, Dianne Nguyen

Rheumatology (Oxford)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis.
Alvin F Wells, Maria Greenwald, John D Bradley, Jahangir Alam, Vipin Arora

Rheumatol Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor-Alpha Experienced Rheumatoid Arthritis.
Alvin F Wells, Jeffrey R Curtis, Keith A Betts, Kevin Douglas, Ella Xiaoyan Du

Clin Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of the current treatment landscape for rheumatology patients in Qatar: Recognising unmet needs and moving towards solutions.
Samar Al Emadi, Mohammed Hammoudeh, Mohamed Mounir, Ruediger B Mueller, Alvin F Wells

J Int Med Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
Gurjit S Kaeley, Midori J Nishio, Janak R Goyal, Daryl K MacCarter, Alvin F Wells

Arthritis Rheumatol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis.
Hunar Abdulrahim, Samuel Thistleton, Adewale O Adebajo, Tim Shaw, Christopher Edwards, Alvin Wells

Expert Opin Pharmacother· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.
Arthur Kavanaugh, Alvin F Wells

Rheumatology (Oxford)· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations.
Alvin F Wells, Nicole Jodat, Michael Schiff

Biologics· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating health information technology and electronic health records into the management of fibromyalgia.
Alvin F Wells, Lesley M Arnold, Cassandra E Curtis, L Jean Dunegan, Charles W Lapp

Postgrad Med· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 2013 Rheumatology Winter Clinical Symposia.
Arthur Kavanaugh, Roy Fleischmann, Martin Jan Bergman, Eric Ruderman, Orrin Troum, Alvin F Wells

Semin Arthritis Rheum· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual Conference.
Philip G Conaghan, Mikkel Ostergaard, Maria Antonietta D'Agostino, Norman Gaylis, William Arnold, Alvin Wells

Semin Arthritis Rheum· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis